These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8865978)

  • 1. Plasma immunoreactive endothelin-1 concentrations in infants with persistent pulmonary hypertension of the newborn.
    Kumar P; Kazzi NJ; Shankaran S
    Am J Perinatol; 1996 Aug; 13(6):335-41. PubMed ID: 8865978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin-1 levels in infants with pulmonary hypertension receiving extracorporeal membrane oxygenation.
    Macdonald PD; Paton RD; Logan RW; Skeoch CH; Davis CF
    J Perinat Med; 1999; 27(3):216-20. PubMed ID: 10503184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn.
    Reynolds EW; Ellington JG; Vranicar M; Bada HS
    Pediatrics; 2004 Nov; 114(5):1297-304. PubMed ID: 15520111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of endogenous endothelin-1 and inhaled nitric oxide in term and preterm infants.
    Truog WE; Pallotto E; Clark P; Banks B; Kaftan HA; Ekekezie II; Norberg M; Ballard RA
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():294S-297S. PubMed ID: 12193107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated immunoreactive endothelin-1 levels in newborn infants with persistent pulmonary hypertension.
    Rosenberg AA; Kennaugh J; Koppenhafer SL; Loomis M; Chatfield BA; Abman SH
    J Pediatr; 1993 Jul; 123(1):109-14. PubMed ID: 8320603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary dysfunction and therapeutic hypothermia in asphyxiated newborns: whole body versus selective head cooling.
    Sarkar S; Barks JD; Bhagat I; Dechert R; Donn SM
    Am J Perinatol; 2009 Apr; 26(4):265-70. PubMed ID: 19021092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary nitrite and nitrate concentrations in patients with idiopathic persistent pulmonary hypertension of the newborn and effect of extracorporeal membrane oxygenation.
    Dollberg S; Warner BW; Myatt L
    Pediatr Res; 1995 Jan; 37(1):31-4. PubMed ID: 7700731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma and urinary endothelin-1 concentrations in asphyxiated newborns [corrected].
    Tekin N; Dinleyici EC; Aksit MA; Kural N; Erol K
    Neuro Endocrinol Lett; 2007 Jun; 28(3):284-8. PubMed ID: 17627263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous negative pressure in the treatment of infants with pulmonary hypertension and respiratory failure.
    Sills JH; Cvetnic WG; Pietz J
    J Perinatol; 1989 Mar; 9(1):43-8. PubMed ID: 2651595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of inhaled nitric oxide on endothelin-1 and cyclic guanosine 5'-monophosphate plasma concentrations in newborn infants with persistent pulmonary hypertension.
    Christou H; Adatia I; Van Marter LJ; Kane JW; Thompson JE; Stark AR; Wessel DL; Kourembanas S
    J Pediatr; 1997 Apr; 130(4):603-11. PubMed ID: 9108859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous nitric oxide and endothelin-1 in persistent pulmonary hypertension of the newborn.
    Endo A; Ayusawa M; Minato M; Takada M; Takahashi S; Harada K
    Eur J Pediatr; 2001 Apr; 160(4):217-22. PubMed ID: 11317642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine infusion improves oxygenation in term infants with respiratory failure.
    Konduri GG; Garcia DC; Kazzi NJ; Shankaran S
    Pediatrics; 1996 Mar; 97(3):295-300. PubMed ID: 8604260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endotracheal tolazoline administration in neonates with persistent pulmonary hypertension.
    Parida SK; Baker S; Kuhn R; Desai N; Pauly TH
    J Perinatol; 1997; 17(6):461-4. PubMed ID: 9447533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Airway function in infants treated with inhaled nitric oxide for persistent pulmonary hypertension.
    Hoskote AU; Castle RA; Hoo AF; Lum S; Ranganathan SC; Mok QQ; Stocks J
    Pediatr Pulmonol; 2008 Mar; 43(3):224-35. PubMed ID: 18203182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma thromboxane and pulmonary artery pressure in neonates treated with extracorporeal membrane oxygenation.
    Bui KC; Martin G; Kammerman LA; Hammerman C; Hill V; Short BL
    J Thorac Cardiovasc Surg; 1992 Jul; 104(1):124-9. PubMed ID: 1614197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient pulmonary vascular lability: a form of mild pulmonary hypertension of the newborn not requiring mechanical ventilation.
    Bonta BW
    J Perinatol; 1988; 8(1):19-23. PubMed ID: 3236088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of high-frequency flow interruption ventilation and hyperventilation in persistent pulmonary hypertension of the newborn.
    Jirapaet KS; Kiatchuskul P; Kolatat T; Srisuparb P
    Respir Care; 2001 Jun; 46(6):586-94. PubMed ID: 11353547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma immunoreactive endothelin-1 concentration in cord blood of normal term neonates.
    Kumar P; Kazzi NJ; Shankaran S
    Am J Perinatol; 1995 Mar; 12(2):113-5. PubMed ID: 7779191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A staged protocol for the treatment of persistent pulmonary hypertension of the newborn.
    Sasse S; Kribs A; Vierzig A; Roth B
    Klin Padiatr; 1997; 209(5):301-7. PubMed ID: 9342718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma endothelin 1 concentrations in children with congenital heart defects.
    Jia B; Zhang S; Chen Z; Li Z; Li X; Hui W; Ye M
    Minerva Pediatr; 1998 Apr; 50(4):99-103. PubMed ID: 9808961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.